QR-Code

ROS-triggerable dual nanocoated probiotics for inflammatory bowel disease treatment

Inflammatory bowel disease (IBD), an immune-mediated chronic gastrointestinal disease, is difficult to treat because its specific pathogenic mechanisms are currently unclear, and its recurrence rate is high. Probiotic therapies have been used to treat IBD; however, challenges, including poor digesti...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Guangze Sang, Sizhen Wang, Qiwei Tai, Yunchang Zhang, Xufang Wang, Baoling Yan, Weiwei Jiang, Zhendong Chen, Linhong Sun, Jiao Zhou, Xiaoxian Wu, Zi Ye, Feng Yang, Jun Luo, Beibei Guo
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis Group 2026-12-01
Schriftenreihe:Drug Delivery
Schlagworte:
Inflammatory bowel disease
ulcerative colitis
probiotics
catechin
Escherichia coli Nissle 1917
Online-Zugang:https://www.tandfonline.com/doi/10.1080/10717544.2026.2630460
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge